These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 29610194

  • 1. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
    García-de-la-Mària C, Gasch O, García-Gonzalez J, Soy D, Shaw E, Ambrosioni J, Almela M, Pericàs JM, Tellez A, Falces C, Hernandez-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Pujol M, Moreno A, Marco F, Miró JM.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
    Castañeda X, García-De-la-Mària C, Gasch O, Pericàs JM, Soy D, Cañas-Pacheco MA, Falces C, García-González J, Hernández-Meneses M, Vidal B, Almela M, Quintana E, Tolosana JM, Fuster D, Llopis J, Dahl A, Moreno A, Marco F, Miró JM, Hospital Clínic Endocarditis Study Group.
    J Antimicrob Chemother; 2021 May 12; 76(6):1539-1546. PubMed ID: 33837406
    [Abstract] [Full Text] [Related]

  • 3. Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
    García-de-la-Mària C, Gasch O, Castañeda X, García-González J, Soy D, Cañas MA, Ambrosioni J, Almela M, Pericàs JM, Téllez A, Falces C, Hernández-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Moreno A, Marco F, Miró JM, Hospital Clínic Endocarditis Study Group.
    J Antimicrob Chemother; 2020 Dec 01; 75(12):3586-3592. PubMed ID: 32853336
    [Abstract] [Full Text] [Related]

  • 4. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
    del Río A, García-de-la-Mària C, Entenza JM, Gasch O, Armero Y, Soy D, Mestres CA, Pericás JM, Falces C, Ninot S, Almela M, Cervera C, Gatell JM, Moreno A, Moreillon P, Marco F, Miró JM, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2016 Jan 01; 60(1):478-86. PubMed ID: 26525803
    [Abstract] [Full Text] [Related]

  • 5. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
    Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2012 Aug 01; 56(8):4511-5. PubMed ID: 22644033
    [Abstract] [Full Text] [Related]

  • 6. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Miró JM, García-de-la-Mària C, Armero Y, Soy D, Moreno A, del Río A, Almela M, Sarasa M, Mestres CA, Gatell JM, Jiménez de Anta MT, Marco F, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2009 Oct 01; 53(10):4172-7. PubMed ID: 19620326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ, Barber KE, Ireland CE, Rybak MJ.
    Antimicrob Agents Chemother; 2014 Jun 01; 58(6):3177-81. PubMed ID: 24663016
    [Abstract] [Full Text] [Related]

  • 9. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2008 Jul 01; 52(7):2538-43. PubMed ID: 18426900
    [Abstract] [Full Text] [Related]

  • 10. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ, Hady WA, Bayer AS, Chen L, Kreiswirth BN, Yang SJ.
    Antimicrob Agents Chemother; 2012 Nov 01; 56(11):5528-33. PubMed ID: 22890759
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    Duss FR, Garcia de la Mària C, Croxatto A, Giulieri S, Lamoth F, Manuel O, Miró JM.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2626-2630. PubMed ID: 31298264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L, Glauser MP, Bille J.
    Antimicrob Agents Chemother; 1990 Dec 01; 34(12):2348-53. PubMed ID: 1965105
    [Abstract] [Full Text] [Related]

  • 14. Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.
    Lingscheid T, Poeppl W, Bernitzky D, Veletzky L, Kussmann M, Plasenzotti R, Burgmann H.
    Antimicrob Agents Chemother; 2015 Feb 01; 59(2):859-63. PubMed ID: 25403675
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT.
    Antimicrob Agents Chemother; 2003 May 01; 47(5):1714-8. PubMed ID: 12709345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
    Tattevin P, Basuino L, Bauer D, Diep BA, Chambers HF.
    Antimicrob Agents Chemother; 2010 Feb 01; 54(2):610-3. PubMed ID: 19917746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.